Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
| ▸ | APLNR | P35414 | 3/20 | 0.46 |
| ▸ | TSPO | P30536 | 1/20 | 0.44 |
| ▸ | BCHE | P06276 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20871284 | 1.00 | TAAR1 (0.52) | TAAR1ALDH1A1CNR1CNR2LMNA | |
| SCHEMBL20871285 | 0.93 | TAAR1 (0.57) | TAAR1ALDH1A1CNR1CNR2APLNR | |
| SCHEMBL20871404 | 0.86 | CNR1 (0.47) | TAAR1ALDH1A1CNR1CNR2LMNA | |
| SCHEMBL22340664 | 0.86 | CNR1 (0.47) | TAAR1ALDH1A1CNR1CNR2LMNA | |
| SCHEMBL22340682 | 0.86 | TAAR1 (0.51) | TAAR1ALDH1A1CNR1CNR2APLNR | |
| SCHEMBL29335354 | 0.86 | BCL2A1 (0.52) | TAAR1ALDH1A1CNR2APLNRTDP1 | |
| SCHEMBL20871276 | 0.86 | TAAR1 (0.51) | TAAR1ALDH1A1LMNANPSR1APLNR | |
| SCHEMBL29335353 | 0.86 | TAAR1 (0.51) | TAAR1ALDH1A1CNR1CNR2LMNA | |
| SCHEMBL11669812 | 0.85 | TAAR1 (0.54) | TAAR1ALDH1A1CNR1CNR2LMNA | |
| SCHEMBL22340948 | 0.84 | CNR1 (0.45) | TAAR1ALDH1A1CNR1CNR2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3707132-B1 | NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES | UNIV PARIS SACLAY (FR) | 2024-07-17 | — | — | EP | disclosed |
| US-11034646-B2 | Method for the synthesis of unsymmetrical tertiary amines | Universite Paris-Saclay (FR) | 2021-06-15 | — | — | US | disclosed |
| US-20200255369-A1 | NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES | Universite Paris-Saclay (FR) | 2020-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200255369-A1 | NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES | ADH1C, ADH1A, ADH5 | TAAR1 13/4885ALDH1A1 179/4885CNR1 1297/4885 |
| US-11034646-B2 | Method for the synthesis of unsymmetrical tertiary amines | ADH1C, PNMT, ADH1A | TAAR1 23/4885ALDH1A1 182/4885CNR1 1767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.